Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes
about
Differential effects of Tat proteins derived from HIV-1 subtypes B and recombinant CRF02_AG on human brain microvascular endothelial cells: implications for blood-brain barrier dysfunctionHIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells.Differential regulation of indoleamine-2,3-dioxygenase (IDO) by HIV type 1 clade B and C Tat proteinDifferential effects of HIV type 1 clade B and clade C Tat protein on expression of proinflammatory and antiinflammatory cytokines by primary monocytes.Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins.The gp120 protein is a second determinant of decreased neurovirulence of Indian HIV-1C isolates compared to southern African HIV-1C isolates.Structural and functional studies of CCAAT/enhancer binding sites within the human immunodeficiency virus type 1 subtype C LTR.Immunoneuropathogenesis of HIV-1 clades B and C: role of redox expression and thiol modification.Anti-tat Hutat2:Fc mediated protection against tat-induced neurotoxicity and HIV-1 replication in human monocyte-derived macrophagesDifferential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins.HIV-1 subtypes B and C Tat differentially impact synaptic plasticity expression and implicates HIV-associated neurocognitive disorders.HIV-1 clade B and C isolates exhibit differential replication: relevance to macrophage-mediated neurotoxicity.Impact of Tat Genetic Variation on HIV-1 DiseaseMultiple NF-κB sites in HIV-1 subtype C long terminal repeat confer superior magnitude of transcription and thereby the enhanced viral predominance.Clade C HIV-1 isolates circulating in Southern Africa exhibit a greater frequency of dicysteine motif-containing Tat variants than those in Southeast Asia and cause increased neurovirulence.CCL2 increases X4-tropic HIV-1 entry into resting CD4+ T cells.What does the structure-function relationship of the HIV-1 Tat protein teach us about developing an AIDS vaccine?CCL2: a potential prognostic marker and target of anti-inflammatory strategy in HIV/AIDS pathogenesis.Genotypical diversity of HIV clades and central nervous system impairment.Multifaceted Impact of Host C-C Chemokine CCL2 in the Immuno-Pathogenesis of HIV-1/M. tuberculosis Co-InfectionViral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND)Differential Mechanisms of Inflammation and Endothelial Dysfunction by HIV-1 Subtype-B and Recombinant CRF02_AG Tat Proteins on Human Brain Microvascular Endothelial Cells: Implications for Viral Neuropathogenesis.Tat is a multifunctional viral protein that modulates cellular gene expression and functions.The Evolving Profile of the Signature Amino Acid Residues in HIV-1 Subtype C Tat.Blood-CSF barrier and compartmentalization of CNS cellular immune response in HIV infection.Biomarkers of chemotaxis and inflammation in cerebrospinal fluid and serum in individuals with HIV-1 subtype C versus B.HIV-1 clade-specific differences in the induction of neuropathogenesis.
P2860
Q28236758-198160EE-E883-45D0-BE6A-811C4FCB0B19Q33581852-E81650EF-56E5-457F-8E73-1E27E7C01D91Q33786188-45E3B114-9C39-4C5D-BEAF-8B7D4F779DFAQ33786297-07C65302-47AC-4200-B450-30F83DF304C7Q33897742-97B80624-91C0-4E7C-8658-10BA52AF404DQ34134168-3A6FA149-3F6D-4A9E-9656-0781BAA7979FQ34387337-009B7773-200C-42D4-B571-D4CEAF33AA45Q34415545-0E555594-E87A-4261-B3CE-B74CA0D187D7Q34632979-49824855-37DE-4EFD-936F-97261982A69CQ35003533-7AA0B520-2698-413E-8825-E82A82E9CAB9Q36010129-D4AFFB9D-7C9F-461B-B5F7-6663DF7F946EQ36124813-4B722A90-2D2A-4A92-8E49-53709C9332B8Q36148507-87A061A6-E3C8-450D-978E-90A1C2422D4DQ36492916-E7F955B3-7984-4B59-BBD6-3C22D7B7560DQ36940756-406ADB02-76F0-4818-9332-9EA81D6987D8Q36957794-05C12CEC-42BB-4F2A-BF19-69AD3A4EC984Q37220038-6F9D4723-5944-4739-A1CB-64F52BC94250Q37955129-1AE45E9E-B8B1-4784-8F97-062EC3B08737Q37980665-7822E9A8-02DA-4E3A-90A3-8E4D5B926AD7Q38151096-BD69DBDA-3B5F-4D9A-8B4C-8B608349887FQ38217388-87C70A26-EDF6-400A-9B6E-25B52F6FBF47Q38996141-0F0E7908-3A18-4CC5-933F-163C834EBC1DQ39130522-8D20AA70-6355-42F3-9732-1D5A0A31B9C6Q40200860-FFB97FFA-64B4-4B9A-BFD2-3B09A532DE93Q40455681-C06F0E2D-7FBD-4771-9E98-30A2A4825927Q40618194-FD9B5E72-CCDD-4B7A-AF5F-D75DA1C973E1Q43251339-D206DB2D-8A8C-4852-96B6-80B53D98F6B9
P2860
Human immunodeficiency virus type 1 subtype C Tat fails to induce intracellular calcium flux and induces reduced tumor necrosis factor production from monocytes
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Human immunodeficiency virus t ...... ctor production from monocytes
@ast
Human immunodeficiency virus t ...... ctor production from monocytes
@en
type
label
Human immunodeficiency virus t ...... ctor production from monocytes
@ast
Human immunodeficiency virus t ...... ctor production from monocytes
@en
prefLabel
Human immunodeficiency virus t ...... ctor production from monocytes
@ast
Human immunodeficiency virus t ...... ctor production from monocytes
@en
P2093
P2860
P356
P1433
P1476
Human immunodeficiency virus t ...... ctor production from monocytes
@en
P2093
Erwann P Loret
Grant R Campbell
Jennifer D Watkins
Kumud K Singh
Stephen A Spector
P2860
P304
P356
10.1128/JVI.01938-06
P407
P577
2007-03-21T00:00:00Z